454 related articles for article (PubMed ID: 30041013)
41. Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model.
Vulin M; Zhong Y; Maloney BJ; Bauer B; Hartz AMS
Fluids Barriers CNS; 2023 Oct; 20(1):70. PubMed ID: 37803468
[TBL] [Abstract][Full Text] [Related]
42. MDR1-P-glycoprotein (ABCB1)-mediated disposition of amyloid-β peptides: implications for the pathogenesis and therapy of Alzheimer's disease.
Jedlitschky G; Vogelgesang S; Kroemer HK
Clin Pharmacol Ther; 2010 Oct; 88(4):441-3. PubMed ID: 20856238
[TBL] [Abstract][Full Text] [Related]
43. Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model.
Ding Y; Zhong Y; Baldeshwiler A; Abner EL; Bauer B; Hartz AMS
Fluids Barriers CNS; 2021 Mar; 18(1):10. PubMed ID: 33676539
[TBL] [Abstract][Full Text] [Related]
44. LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-beta peptide in a blood-brain barrier in vitro model.
Nazer B; Hong S; Selkoe DJ
Neurobiol Dis; 2008 Apr; 30(1):94-102. PubMed ID: 18289866
[TBL] [Abstract][Full Text] [Related]
45. Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger S; Pietrzik CU
Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
[TBL] [Abstract][Full Text] [Related]
46. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.
Hartz AM; Miller DS; Bauer B
Mol Pharmacol; 2010 May; 77(5):715-23. PubMed ID: 20101004
[TBL] [Abstract][Full Text] [Related]
47. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells.
Yamada K; Hashimoto T; Yabuki C; Nagae Y; Tachikawa M; Strickland DK; Liu Q; Bu G; Basak JM; Holtzman DM; Ohtsuki S; Terasaki T; Iwatsubo T
J Biol Chem; 2008 Dec; 283(50):34554-62. PubMed ID: 18940800
[TBL] [Abstract][Full Text] [Related]
48. Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease.
Pflanzner T; Kuhlmann CR; Pietrzik CU
Curr Alzheimer Res; 2010 Nov; 7(7):578-90. PubMed ID: 20704558
[TBL] [Abstract][Full Text] [Related]
49. IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.
Deane R; Sagare A; Hamm K; Parisi M; LaRue B; Guo H; Wu Z; Holtzman DM; Zlokovic BV
J Neurosci; 2005 Dec; 25(50):11495-503. PubMed ID: 16354907
[TBL] [Abstract][Full Text] [Related]
50. ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells.
Lee J; Lee H; Lee H; Shin M; Shin MG; Seo J; Lee EJ; Park SA; Park S
Nat Commun; 2023 Dec; 14(1):8463. PubMed ID: 38123547
[TBL] [Abstract][Full Text] [Related]
51. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.
Zlokovic BV; Deane R; Sagare AP; Bell RD; Winkler EA
J Neurochem; 2010 Dec; 115(5):1077-89. PubMed ID: 20854368
[TBL] [Abstract][Full Text] [Related]
52. Mitogen-activated protein kinase signaling pathways promote low-density lipoprotein receptor-related protein 1-mediated internalization of beta-amyloid protein in primary cortical neurons.
Yang WN; Ma KG; Qian YH; Zhang JS; Feng GF; Shi LL; Zhang ZC; Liu ZH
Int J Biochem Cell Biol; 2015 Jul; 64():252-64. PubMed ID: 25936756
[TBL] [Abstract][Full Text] [Related]
53. Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.
Qosa H; LeVine H; Keller JN; Kaddoumi A
Biochim Biophys Acta; 2014 Sep; 1842(9):1806-15. PubMed ID: 24997450
[TBL] [Abstract][Full Text] [Related]
54. The role of the ATP-binding cassette transporter P-glycoprotein in the transport of β-amyloid across the blood-brain barrier.
Vogelgesang S; Jedlitschky G; Brenn A; Walker LC
Curr Pharm Des; 2011; 17(26):2778-86. PubMed ID: 21827406
[TBL] [Abstract][Full Text] [Related]
55. Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier.
Osgood D; Miller MC; Messier AA; Gonzalez L; Silverberg GD
Neurobiol Aging; 2017 Sep; 57():178-185. PubMed ID: 28654861
[TBL] [Abstract][Full Text] [Related]
56. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
[TBL] [Abstract][Full Text] [Related]
57. Role of P-glycoprotein in mediating rivastigmine effect on amyloid-β brain load and related pathology in Alzheimer's disease mouse model.
Mohamed LA; Keller JN; Kaddoumi A
Biochim Biophys Acta; 2016 Apr; 1862(4):778-787. PubMed ID: 26780497
[TBL] [Abstract][Full Text] [Related]
58. Role of ABC transporters in the pathogenesis of Alzheimer's disease.
Abuznait AH; Kaddoumi A
ACS Chem Neurosci; 2012 Nov; 3(11):820-31. PubMed ID: 23181169
[TBL] [Abstract][Full Text] [Related]
59. Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.
Bachmeier C; Shackleton B; Ojo J; Paris D; Mullan M; Crawford F
Neuromolecular Med; 2014 Dec; 16(4):686-96. PubMed ID: 25015123
[TBL] [Abstract][Full Text] [Related]
60. The p38 mitogen-activated protein kinase signaling pathway is involved in regulating low-density lipoprotein receptor-related protein 1-mediated β-amyloid protein internalization in mouse brain.
Ma KG; Lv J; Hu XD; Shi LL; Chang KW; Chen XL; Qian YH; Yang WN; Qu QM
Int J Biochem Cell Biol; 2016 Jul; 76():75-86. PubMed ID: 27163530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
